Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-07-17

Clinical Trial Update: A Observational Study to Evaluate Lipid-lowering Drug Its Effect on Parameters in Dyslipidemia of Type 2 Diabetes.

View source ↗

Summary

This is a completed observational clinical trial assessing the impact of a lipid-lowering drug on lipid and metabolic parameters in dyslipidemia associated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Complex Dyslipidemia | Status: COMPLETED